Elevated circulating hsCRP and pro-inflammatory adipocytokines like FABP4, leptin and lipocalin-2 increase the risk for cardiovascular disease[1, 13, 18] by not only endocrine but also paracrine mechanisms[1]. Here, LEP is linked to cardiovascular disorder.